MedPath

Transbronchial Lung Biopsy Guided by ENB

Not Applicable
Completed
Conditions
Lung Lesion(s) Requiring Evaluation
Registration Number
NCT03628222
Lead Sponsor
Changzhou LungHealth Medtech Company Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
226
Inclusion Criteria

Inclusion Criteria:<br><br> - 18 years and older;<br><br> - Subject presents with PLL(s) detected by chest CT scan and biopsy diagnosis is<br> needed;<br><br> - Subject is willing to receive bronchoscopy voluntarily, and meets relevant<br> requirements;<br><br> - Subject or their guardian understands the purpose of this trial, and willing to<br> participate in the trial voluntarily and sign Informed Consent Form (ICF).<br><br>Exclusion Criteria:<br><br> - Subject has participated in a drug or device study (drug study within 3 months or<br> device study within 1 month);<br><br> - Female subject who is pregnant or nursing;<br><br> - Allergic to anesthetic;<br><br> - Bronchoscopy contraindications, include: Active hemoptysis; Newly developed<br> myocardial infarction or unstable angina attack; Severe cardiac and pulmonary<br> dysfunction; Severe hypertension and arrhythmia; Uncorrectable bleeding tendency<br> (Such as severe clotting dysfunction, uremia, and severe pulmonary hypertension,<br> etc.); Severe superior vena cava obstructive syndrome; Suspected aortic aneurysm;<br> Multiple lung bullae; Extremely exhausted systemic conditions;<br><br> - Subject with serious lung disease (Such as: severe bronchiectasis, severe emphysema,<br> etc) ,which investigator considers not appropriate for this examination;<br><br> - Subject with implanted pacemaker or defibrillator;<br><br> - Lack of patient cooperation for bronchoscopy, such as patient with mental disorders,<br> dysgnosia, psychological disorder etc;<br><br> - Conditions investigator considers not appropriate for this trial.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Compare the diagnostic yield of ENB-TBLB with that of X-ray-TBLB
Secondary Outcome Measures
NameTimeMethod
Incidence of navigation success;Lesion detection rate;Navigation time;Evaluate the user satisfaction of ENB system and system kit;The adverse events and device defects related to the ENB system and system kit
© Copyright 2025. All Rights Reserved by MedPath